Bath & Body Works, Inc. $BBWI Shares Purchased by Bank of America Corp DE

Key Points

• Bank of America increased its Bath & Body Works stake by 26.2% in the first quarter, adding 425,248 shares to own 2.05 million shares valued at $38.3 million. Institutional investors and hedge funds collectively own 95.14% of the company.
• Analysts remain cautious, with a consensus “Hold” rating and an average price target of $21.93. Ratings include three Buys, fourteen Holds and one Sell.
• BBWI opened at $18.62, while its latest quarter beat earnings and revenue estimates despite year-over-year revenue declining 3.2%. The company also declared a quarterly dividend of $0.20, equivalent to a 4.3% annualized yield.

Bank of America Corp DE grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 26.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,050,414 shares of the company's stock after buying an additional 425,248 shares during the period. Bank of America Corp DE owned 1.02% of Bath & Body Works worth $38,281,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in BBWI. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the 4th quarter worth about $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works during the 4th quarter worth about $32,000. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after buying an additional 567 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in shares of Bath & Body Works during the third quarter worth about $39,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on BBWI. Wells Fargo & Company upped their price objective on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an "overweight" rating in a research note on Tuesday, June 23rd. Barclays lowered their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an "equal weight" rating for the company in a research note on Thursday, May 28th. UBS Group cut their price target on Bath & Body Works from $22.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, May 20th. Piper Sandler started coverage on Bath & Body Works in a research note on Friday, May 15th. They set a "neutral" rating and a $20.00 price target on the stock. Finally, Morgan Stanley restated an "equal weight" rating and set a $22.00 price objective on shares of Bath & Body Works in a report on Monday, July 6th. Three equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $21.93.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $18.62 on Friday. The firm has a market capitalization of $3.75 billion, a price-to-earnings ratio of 5.23, a price-to-earnings-growth ratio of 1.79 and a beta of 1.38. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $32.32. The company has a 50 day moving average price of $20.33 and a 200 day moving average price of $20.17.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter last year, the business earned $0.49 EPS. Bath & Body Works's revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.3%. Bath & Body Works's dividend payout ratio (DPR) is presently 22.47%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source